Navigation Links
iLuv Now Shipping the All New MultiCharger-X
Date:5/22/2013

Port Washington, NY (PRWEB) May 22, 2013

iLuv Creative Technology, the premier provider of the most comprehensive line of accessories for the mobile lifestyle, announces they are now shipping MultiCharger-X, an easy way to charge, sync, protect, and manage multiple iPad devices efficiently. Winner of the 2013 internationally recognized iF product design award and the 2012 Good Design award, MultiCharger-X is revolutionizing the way businesses, schools, and medical offices utilize the iPad, wherever it is deployed.

MultiCharger-X (iAD910) combines the best of form and function. This 10-bay charger for the iPad was built with a minimalistic exterior to better match the iPad and other iOS devices it was designed to work with. MultiCharger-X was created with the end user in mind, namely schools, IT managers and even tech novices. It has rounded corners for safety, handles and optional attachable wheels for portability, and a locking door for security. It also features individual 3-color LED lights that indicate when the iPad devices are charging, has charged or is syncing. MultiCharger-X can even be daisy-chained to two additional units to sync up to 30 iPad devices. It allows users to sync data, menus and updates across multiple iPad devices, making it an ideal tool to help manage high-tech investments. Additionally, MultiCharger-X will work with any of your new Lightning pin devices including new Lightning pin iPad 3s and iPad minis.

“iLuv is excited to announce that our first-ever accessory specifically geared towards the enterprise customer, the MultiCharger-X, is now available,” said Jason Park, Marketing Manager at iLuv Creative Technology. “Tablet use in enterprises, including small businesses, restaurants and medical offices has seen tremendous growth in recent years. Mu
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Mold Sufferers Get 20% Discount, Zero Shipping Charge and Complimentary Sample of Non-Toxic Mold Sprays for Valentine's Special, My Cleaning Products Reveals the Details
2. Time bomb: Military ordnance in Gulf poses threat to shipping, says Texas A&M proffesor
3. Marken Launches Exclusive Shipping System for Specimen Logistics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  Prima Biomed Ltd. ... that is striving to become a leader in the ... recently announced that the final CVac data from the ... a clear trend for a clinically meaningful improvement in ... second remission patients. In the group of ...
(Date:5/21/2015)...  The EveryLife Foundation for Rare Diseases applauded ... Amy Klobuchar (D-MN) today for introducing the ... or OPEN ACT. Supported by more ... bipartisan legislation promises to rapidly bring hundreds of ... patients by incentivizing drug makers to "repurpose" approved ...
(Date:5/21/2015)... 2015 W. R. Grace & ... in Worms, Germany has received good manufacturing practice ... the International Pharmaceutical Excipient Council (IPEC) Foundation. ... its SYLOID® FP brand of pharmaceutical grade excipient ... the Curtis Bay, Maryland (USA) and Sorocaba, Brazil ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
Breaking Biology Technology:Correction Continues after Big Move - BrokerBank Securities, Inc. 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7
... March 28, 2011 DRIVE4COPD, the nation,s single largest ... named PRWeek,s Healthcare Campaign of the Year ... the most prestigious honors in the public relations industry, ... and education teams.  Boehringer Ingelheim Pharmaceuticals, Inc. is the ...
... March 28, 2011 Clinicians now have a new tool ... and HSV2) -- one of the most common sexually transmitted ... segment of BD (Becton, Dickinson and Company), announced today that ... for the first fully automated molecular tests to detect and ...
... March 28, 2011 BioMarin Pharmaceutical Inc. ... that Jean-Jacques Bienaime, Chief Executive Officer of ... webcast on Thursday, April 28, at 5:00 ... financial results.U.S. / Canada Dial-in Number:  888.396.2386International ...
Cached Biology Technology:DRIVE4COPD Wins PRWeek Healthcare Campaign of the Year 2011 2DRIVE4COPD Wins PRWeek Healthcare Campaign of the Year 2011 3DRIVE4COPD Wins PRWeek Healthcare Campaign of the Year 2011 4BD Diagnostics Receives FDA Clearance for First Fully Automated Molecular Assays for HSV1 and HSV2 from Clinician-Collected External Anogenital Lesion Specimens 2BioMarin to Host First Quarter 2011 Financial Results Conference Call and Webcast on Thursday, April 28 at 5:00 p.m. ET 2
(Date:4/17/2015)... 2015 Increasing adoption ... advancement to drive biometric systems market in ... According to a recently released TechSci ... ", biometric systems market in Saudi ... at CAGR of over 22% through 2020. The ...
(Date:4/13/2015)... 13, 2015 According to ... Biometrics Market Forecast & Opportunities, 2020", the global biometrics ... around 14% till 2020. The biometrics market is ... implementation and review of biometric management systems. The ... products with greater efficiency, are resulting in increasing ...
(Date:4/9/2015)... April 9, 2015 Synaptics Inc. (NASDAQ: SYNA ... today that it will report financial results for the ... 2015, after the close of market. The company will ... at 2:00 p.m. PT (5:00 p.m. ET), during which ... participate on the live call, analysts and investors should ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2Synaptics to Report Third Quarter Results on April 23 2
... November 9, 2010 The Ontario Genomics Institute (OGI) ... at St. Joan of Arc Catholic Secondary School (Mississauga, ... Prize. The annual prize recognizes the Ontario secondary ... preparing Ontario,s students for their future roles: perhaps ...
... University of Toronto have shown that the nature of ... individual,s sensitivity to physical pain. The discovery could ... general well-being of an individual on a daily basis. ... have demonstrated the impact of inadequate social connectedness on ...
... activity of nerve cells in a songbird,s brain as it ... in the Department of Physics at Penn State University and ... string together sets of syllables -- or notes in a ... brain learns language and produces speech. The research will be ...
Cached Biology News:Mississauga teacher awarded prize for excellence in teaching genomics 2Mississauga teacher awarded prize for excellence in teaching genomics 3Psychologists identify influence of social interaction on sensitivity to physical pain 2Scientists discover how the songbird's brain controls timing during singing 2
... a special preparation of bovine pancreatic DNase I ... of DNA molecules. In the presence of Mn2+ ... strand breaks at random sites in DNA. The ... controlled by the enzyme concentration and incubation time. ...
... potent TURBO DNase (patent pending) in the TURBO ... DNA removal capabilities. TURBO DNase is a recombinant, ... more efficient than wild type DNase I in ... DNase binds DNA substrates 6-fold more tightly than ...
... IEC Centra CL3 series is designed ... research and clinical applications at a ... package includes quick connect rotors and ... yet intuitive interface allows you to ...
Porcine Pulmonary Artery Endothelial Cells (PPAEC) (>500,000 cells)...
Biology Products: